An inhalable virus-like-particle vaccine against COVID-19
An inhalable virus-like-particle consisting of exosomes decorated with a recombinant SARS-Cov-2 receptor-binding domain is stable at room temperature and elicits systemic and mucosal immune responses in small animals.
Published in Bioengineering & Biotechnology
The cover illustrates an inhalable virus-like-particle vaccine made of exosomes derived from lung cells and decorated with a recombinant SARS-CoV-2 receptor-binding domain.
Image: Kate Zvorykina. Cover design: Alex Wing.
Follow the Topic
Biotechnology
Life Sciences > Biological Sciences > Biotechnology
-
Nature Biomedical Engineering
This journal aspires to become the most prominent publishing venue in biomedical engineering by bringing together the most important advances in the discipline, enhancing their visibility, and providing overviews of the state of the art in each field.
Related Collections
With Collections, you can get published faster and increase your visibility.
Biosensing
With this cross-journal Collection, the editors of Communications Biology, Nature Biomedical Engineering, Nature Sensors, Nature Communications, and Scientific Reports welcome the submission of primary research Articles focusing on the development of engineered biosensing devices with the potential to be applied in biomedical research and in the management of disease conditions.
Publishing Model: Hybrid
Deadline: Mar 26, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in